Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page’s interface/version footer was updated from revision v3.5.2 to v3.5.3, reflecting a minor maintenance release to ClinicalTrials.gov rather than a change to the underlying study record.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision v3.5.2 was added and Revision v3.5.0 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added, replacing the previous v3.4.1 label on the history page.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or page layout are visible.SummaryDifference0.0%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.